First Choice Bio is revolutionizing preclinical research with its AI-driven “Smart Samples,” offering high-quality, diverse human cell samples enriched with real-time clinical data to improve reproducibility and accelerate drug development. By integrating advanced data analytics, strategic partnerships, and ethical donor recruitment, they aim to enhance research precision, reduce waste, and drive more effective, individualized treatments.